OWL-LABS
26.1.2021 09:02:03 CET | Business Wire | Press release
Owl Labs , the award-winning leader in immersive and collaborative video conferencing technology and services, today announced an alliance with Ingram Micro, the world’s largest distributor and provider of technology services and solutions. The new distribution agreement expands Owl Labs’ reach across Europe and strengthens Owl Labs’ presence within key European markets.
Through Owl Labs working relationship with Ingram Micro, Owl Labs will now be able to expand the reach and accessibility of its award-winning flagship product, the Meeting Owl Pro, to one centralised distribution warehouse in Straubing, Germany, and from that single point will support its supply chain into 17 distribution centers across Europe, trading across all 28 countries. Ingram Micro serves a diverse base of resellers and 2,000+ of the world’s most recognized IT and mobility technology brands.
With the rapid adoption of hybrid work and remote teams, maintaining effective communication and collaboration regardless of location is more crucial than ever. As more diverse and flexible working patterns continue to become increasingly popular, companies will need to find a better way to connect employees, whether they are in-office or at home. Companies can achieve a seamless collaborative team experience no matter where employees are located with the Meeting Owl Pro. Powered by Owl Labs’ proprietary intelligence technology, the Meeting Owl Pro automatically focuses on who is speaking in a room using audio and visual cues from its high-definition 360° camera, as well as eight microphones and tri-speakers, that have a pickup range of five meters. Through this technology the smart device is able to create a fully immersive, near face-to-face experience for all participants involved, and is also compatible with all popular video conferencing platforms.
“We are thrilled to team up with Ingram Micro, increasing our reach and presence across Europe to expand and strengthen our business. This alliance will make it easier for businesses and educational institutions based in Europe to use Owl Labs’ collaboration technology to help maintain and facilitate clear and effective communication with employees or students, no matter their location.” states Frank Weishaupt, CEO of Owl Labs. “As hybrid and flexible working rises in popularity, there is an increased demand in products and services that help productivity and allow hybrid teams to communicate effectively. We look forward to meeting this demand through our partnership with Ingram Micro.”
Owl Labs' products are used by 50,000+ companies in 156 countries across a wide array of categories, including the likes of the Ogilvy, ClearScore, Bern University of Applied Science, and Prague College. Owl Labs has been recently named AV Technology Awards Communication Technology of the Year, as well as German Design Award Winners and Red Dot Award Recipient. The Owl Labs' Meeting Owl Pro is also named in TIME's List Of The 100 Best Inventions Of 2020.
“ Having the ability to work from anywhere and communicate clearly and securely from everywhere is critical to the future of work,” states Joost Boon, director, Advanced Solutions, UCC Supply Chain and Business Operations, Pan Europe GmbH, Ingram Micro. “We are pleased to welcome Owl Labs to the Ingram Micro Pan Europe portfolio, and look forward to working together with our channel partners to generate greater awareness and demand for Owl Lab’s innovative and immersive video conferencing technology solutions.”
About Owl Labs
Owl Labs is a collaborative technology company revolutionizing the way we connect. Owl Labs creates deeply immersive and inclusive meeting experiences for today’s hybrid workforce and virtual classroom. The company’s flagship product, the award-winning Meeting Owl, features a wifi-enabled, 360-degree camera, mic, and speaker powered by proprietary technology with an automatic zoom that responds to who’s speaking. In 2020, the Meeting Owl Pro was named in TIME’s 100 Best Innovations
.
Owl Labs continues to champion the hybrid work movement with its annual State of Remote Work Report . To learn more about Owl Labs and the full product suite and to join the Work From Anywhere Movement, please visit www.owllabs.com .
About Ingram Micro
Ingram Micro helps businesses realize the promise of technology. It delivers a full spectrum of global technology and supply chain services to businesses around the world. Deep expertise in technology solutions, mobility, cloud, and supply chain solutions enables its business partners to operate efficiently and successfully in the markets they serve. Unrivaled agility, deep market insights and the trust and dependability that come from decades of proven relationships, set Ingram Micro apart and ahead. Discover how Ingram Micro can help you realize the promise of technology. More at www.ingrammicro.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210126005061/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom